Monique E. Cho

Monique E. Cho, MD is an Associate Professor in the Department of Medicine at the University of Utah School of Medicine, specializing in Nephrology & Hypertension. Her clinical practice at the Kidney & Liver Clinic in Salt Lake City focuses on chronic kidney disease management, kidney stones, polycystic kidney disease, and hypertension, with exceptional patient satisfaction reflected in a 5.0/5 rating from 26 verified reviews.

Education:

• B.A. in Psychology from Cornell University
• M.D. from Geisel School of Medicine at Dartmouth
• Internal Medicine Residency at University of Rochester Medical Center
• Nephrology Fellowship at University of Rochester Medical Center
• Senior Clinical Fellow in Training Program in Clinical Research (NIH/Duke University)
• Senior Clinical Fellow in Kidney Disease Branch (NIDDK)

Dr. Cho's research centers on sodium-glucose cotransporter 2 (SGLT2) inhibition for improving vascular and physical function in chronic kidney disease patients. Her work spans three critical domains: vascular pathophysiology in CKD, blood pressure control mechanisms (particularly through SPRINT trial analyses), and veteran health outcomes including homelessness impacts and anemia-dementia relationships. Ongoing projects investigate SGLT2 inhibitors post-heart transplant and iron metabolism in diabetic CKD.

Analysis of her 2021-2025 publications reveals dominant themes in veteran-focused CKD research (40% of recent work), SGLT2 therapeutic applications (25%), and blood pressure-cerebral flow relationships (20%). The SPRINT trial framework underpins 35% of her recent studies, while veteran health system collaborations appear in 30%.

Dr. Cho actively contributes to major research consortia including the SPRINT Research Group and Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Her clinical research bridges nephrology, cardiology, and neurology through multi-institutional veteran health studies and NIH-funded clinical trials investigating novel CKD therapeutics and social determinants of kidney disease progression.